Medical News

Medical News Today: 'Light was as rewarding as morphine' in mice with new opioid receptors

By |May 4th, 2015|

Research neurobiologists and anesthesiologists have created opioid receptors that respond to light in the same way as the binding sites in the brain respond to painkilling drugs.Certain painkilling drugs bind to opioid receptors in the brain and spinal cord.
The laboratory findings in test tubes and animals have been published in the journal Neuron.
The researchers did […]

Researchers suggest ways to keep harmful tobacco and alcohol products away from young people

By |May 4th, 2015|

As the realities of legalized marijuana take hold in four states and the District of Columbia, legislators and regulators could learn a lot from the successes — and failures — of the tobacco and alcohol industries in keeping their harmful products out of the hands of children and adolescents.
So say three Johns Hopkins Bloomberg School […]

Medical News Today: Incidence of neonatal abstinence syndrome almost doubles in 4 years

By |May 3rd, 2015|

Between 2009 and 2012, the number of babies born in the US with neonatal abstinence syndrome – symptoms of drug withdrawal – almost doubled. This is according to a new study published in the Journal of Perinatology.Between 2009 and 2012, the number of babies born with NAS almost doubled, from 3.4 births per 1,000 to […]

Medical News Today: Condom use higher in young HIV-positive women with gender-equal views, study finds

By |May 2nd, 2015|

Perceiving men and women as equals may encourage the practice of safer sex among young women with HIV, a new study finds.HIV-positive women under the age of 26 with more gender-equal views were more likely to have used a condom in their most recent sexual encounter, the study found.
Published in the journal PLOS ONE, the […]

Heart Failure Implant Tied to Weakening of Thinking, Memory

By |May 2nd, 2015|

Heart Failure Implant Tied to Weakening of Thinking, Memory

By Dennis ThompsonHealthDay Reporter

Latest Heart News

THURSDAY, April 30, 2015 (HealthDay News) — A mechanical device that restores a failing heart's ability to pump blood might contribute to a decline in memory and thinking in some patients, a new study reports.
Left ventricular assist devices are surgically implanted in […]

Pre-POINT trial raises hope for Type 1 diabetes prevention

By |May 1st, 2015|

By Eleanor McDermid, Senior medwireNews Reporter
Giving oral insulin to children at genetic high risk of diabetes stimulates a regulatory immune response without inducing hypoglycaemia, show the findings of the Pre-POINT study.
Pre-POINT was a double-blind, placebo-controlled trial that investigated oral insulin doses ranging from 2.5 to 67.5 mg for up to 18 months.
The highest dose was […]

Pneumonic plague transmission from dog to man

By |May 1st, 2015|

Published on May 1, 2015 at 12:02 PM

By Kate Bass
The case of a man in Colorado who contracted human pneumonic plague in June 2014 was published today by the Centers for Disease Control and Protection (CDC). This case was unusual in that plague only affects around eight people annually in the United State, […]

Medical News Today: Lives of three babies rescued by 3D-printed, growth-flexible implants

By |May 1st, 2015|

3D printing has come to the rescue of severe cases of a childhood disease in which the windpipe is softened, leading to collapse of the airway and breathing failure. Previously lacking any adequate intervention, tracheobronchomalacia has found an innovative fix in three babies whose condition presented them with little chance of reaching young childhood.Kaiba Gionfriddo, […]

Pembrolizumab effective, well-tolerated in advanced melanoma patients

By |April 30th, 2015|

By Shreeya Nanda, Senior medwireNews Reporter
Compared with ipilimumab, treatment with pembrolizumab not only significantly improves outcomes, but also results in fewer high-grade adverse events in patients with advanced melanoma, a phase III trial shows.
Indeed, the interim overall survival (OS) results favouring pembrolizumab resulted in early trial closure to allow ipilimumab-treated patients the option of receiving […]

High Throughput ChIP-seq Assay for Genome-wide Protein-DNA Analysis

By |April 30th, 2015|

Published on April 30, 2015 at 1:00 PM

Chromatrap®, a business unit of Porvair Sciences, has published a new application note that describes how Chromatrap® ChIP-seq assays now enable unbiased, genome-wide understanding of protein-DNA regulatory networks.
Genome-wide mapping of protein-DNA interactions is essential for a complete understanding of gene regulation. A detailed map of epigenetic […]